Zusammenfassung
Die Aufklärung der molekulargenetischen Grundlagen der Krebsentstehung hat in den letzten Jahren wesentliche neue Erkenntnisse erbracht, durch die es möglich geworden ist, Patienten mit einem erblich bedingten erhöhten Krebsrisiko durch genetische Untersuchungsmethoden zu identifizieren. Insbesondere bei den erblichen gastrointestinalen Tumorprädispositionssyndromen, allen voran der familiären adenomatösen Polyposis (FAP) und dem hereditären nichtpolypösen kolorektalen Karzinom (HNPCC) konnten so neue interdisziplinäre klinische Konzepte entwickelt werden, die zu einer wesentlichen Verbesserung der Krebsvorsorge und -früherkennung beitragen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Albuquerque C, van der Breukel C et al. (2002) The ›just-right‹ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 11: 1549–1560
Bachmann KD, Bartram CR, Chang-Claude J, Fonatsch C, Propping P (1998) Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Dtsch Arztebl 95: A1396–1403
Bapat B, Noorani H, Cohen Z et al. (1999) Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut 44: 698–703
Bian Y, Caldes T, Wijnen J et al. (2005) TGFBR1*6A may contribute to hereditary colorectal cancer. J Clin Oncol 23: 3074–3078
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ et al. (1998) A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248–5257
Cheadle JP, Sampson JR (2003) Exposing the MYtH about base excision repair and human inherited disease. Hum Mol Genet 12(Spec No 2): R159–R165
Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom J, McGannon E (1996) Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Am J Gastroenterol 91: 2489–2493
Clevers H, van de Wetering M (1997) TCF/LEF factor earn their wings. Trends Genet 13: 485–489
de la Chapelle A (2004) Genetic Predisposition to colorectal cancer. Nat Reviews Cancer 4: 769–780
Dihlmann S, Gebert J, Siermann A, Herfarth C, von Knebel Doeberitz M (1999) Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis. Cancer Res 59: 1857–1860
Dunlop MG, Farrington SM, Carothers AD et al. (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6: 105–110
Duval A, Hamelin R (2002) Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. 10. Cancer Res 62: 2447–2454
Friedl W, Meuschel S, Caspari R, Lamberti C, Krieger S, Sengteller M, Propping P (1996) Attenuated familial adenomatous polyposis due to a mutation in the 3’ part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 97: 579–584
Gebert JF, Dupon C, Kadmon M, Hahn M, Herfarth C, von Knebel Doeberitz M, Schackert HK (1999) Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli. Ann Surg 229: 350–361
Giardiello FM, Brensinger JD, Petersen GM et al. (1997) The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336: 823–827
Goecke T, Schulmann K, Engel C et al. (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol. 24: 4285–4292
He TC, Sparks AB, Rago C et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512
Heppner Goss K, Trzepacz C, Tuohy TM, Groden J (2002) Attenuated APC alleles produce functional protein from internal translation initiation. Proc Natl Acad Sci USA 99: 8161–8166
Hovanes K, Li TW, Munguia JE et al. (2001) Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28: 53–57
Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159–170
Kloor M, von Knebel Doeberitz M, Gebert J (2005) Molecular testing for microsatellite instability and its value in tumor characterization. Expert Rev Mol Diagn 5: 599–611
Kullmann F, Bocker T, Scholmerich J, Ruschoff J (1996) [Microsatellite instability-a new aspects in genetics and molecular biology of hereditary nonpolyposis and sporadic colorectal tumors]. Z Gastroenterol 34: 813–822
Laken SJ, Petersen GM, Gruber SB et al. (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17: 79–83
Linnebacher M, Gebert J, Rudy W, Woerner S, Yuan YP, Bork P, von Knebel DM (2001) Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens. Int J Cancer 93: 6–11
Lynch HT, Smyrk T (1996) Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78: 1149–1167
Lynch HT, Smyrk T, McGinn T et al. (1995) Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 76: 2427–2433
Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348: 919–932
Mann B, Gelos M, Siedow A et al. (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96: 1603–1608
Markowitz S, Wang J, Myeroff L et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338
Okuno S (2006) The enigma of desmoid tumors. Curr Treat Options Oncol 7: 438–443
Peltomaki P, Vasen HF (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113: 1146–1158
Petersen GM (1994) Knowledge of the adenomatous polyposis coli gene and its clinical application. Ann Med 26: 205–208
Polakis P (1999) The oncogenic activation of beta-catenin. Curr Opin Genet Dev 9: 15–21
Powell SM, Petersen GM, Krush AJ et al. (1993) Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329: 1982–1987
Quehenberger F, Vasen HF, van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42: 491–496
Roose J, Huls G, van Beest M, Moerer P, van der Horn HK, Goldschmeding R, Logtenberg T, Clevers H (1999) Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285: 1923–1926
Saeterdal I, Bjorheim J, Lislerud K et al. (2001) Frameshift-mutationderived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 98: 13255–13260
Schwitalle Y, Kloor M, Eiermann S et al. (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134: 988–997
Smith KJ, Johnson KA, Bryan TM et al. (1993) The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 90: 2846–2850
Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130–1134
Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422–426
Vasen HF, van der Luijt RB, Slors JF et al. (1996) Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 348: 433–435
Valle L, Serena-Acedo T, Liyanarachchi S et al. (2008) Germline allelespecific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 321:1361–1365
Veigl ML, Kasturi L, Olechnowicz J et al. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 95: 8698–8702
Wimmer K, Etzler J (2008) Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg. Hum Genet 124: 105–122
Woerner SM, Benner A, Sutter C et al. (2003) Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative real common target genes. Oncogene 22: 2226–2235
Woerner SM, Kloor M, von Knebel Doeberitz M, Gebert JF (2006) Microsatellite instability in the development of DNA mismatch repair deficient tumors. Cancer Biomark 2:69–86
Wu JS, Paul P, McGannon EA, Church JM (1998) APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 227: 57–62
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kloor, M., von Knebel Doeberitz, M., Gebert, J. (2010). Molekulare Pathogenese, Diagnostik und Therapie hereditärer Tumoren des Gastrointestinaltrakts. In: Siewert, J.R., Rothmund, M., Schumpelick, V. (eds) Praxis der Viszeralchirurgie Onkologische Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03808-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-03808-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03807-5
Online ISBN: 978-3-642-03808-2
eBook Packages: Medicine (German Language)